Clinic
Total Medical Care, LLC
Total Medical Care, LLC was paid $15.22M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 28% of everything it billed.
33Billing provider infoTOTAL MEDICAL CARE, LLC
GLENDALE, AZ 85301
GLENDALE, AZ 85301
33aNPI1639306731assigned 06/16/2009
33bProvider typeUrgent Care Clinic/Center
28Total paid$15.22M
24GClaims209,904
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Arizona
Rank by total paid#8 of 81
Median peer was paid$312K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,442 | $2.02M | |
| 2019 | 34,744 | $1.99M | |
| 2020 | 33,938 | $2.37M | |
| 2021 | 33,111 | $2.65M | |
| 2022 | 30,294 | $2.56M | |
| 2023 | 30,104 | $2.59M | |
| 2024incomplete | 17,271 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 28% | 21,453 | 2,947 | $4.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 57,059 | 52,104 | $3.61M |
| 95144 | 17% | 21,973 | 3,056 | $2.53M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 41,764 | 39,041 | $1.97M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 10% | 7,483 | 7,265 | $1.58M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 6,583 | 6,397 | $422K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,481 | 8,914 | $124K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,464 | 1,434 | $114K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,242 | 1,226 | $100K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,143 | 3,051 | $90K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 767 | 765 | $64K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 784 | 772 | $56K |
58 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 707 | $47K |
| 95117 | <1% | 5,682 | $45K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 875 | $30K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,038 | $19K |
| 81002 | <1% | 7,101 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 754 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,427 | $16K |
| 90686 | <1% | 2,152 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 146 | $14K |
| 0011A | <1% | 347 | $10K | |
| 81025 | <1% | 1,494 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 455 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 311 | $8K |
| 20610 | <1% | 219 | $7K | |
| 0012A | <1% | 188 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,447 | $5K |
| 93000 | <1% | 448 | $5K | |
| 0064A | <1% | 138 | $5K | |
| 90756 | <1% | 215 | $3K | |
| 90715 | <1% | 221 | $3K | |
| 95115 | <1% | 527 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 44 | $2K |
| 99385 | <1% | 13 | $1K | |
| 90620 | <1% | 47 | $1K | |
| 93922 | <1% | 28 | $899.05 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12 | $833.16 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 147 | $451.54 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $370.13 |
| 90734 | <1% | 74 | $306.88 | |
| 3078F | <1% | 923 | $210.65 | |
| 0134A | <1% | 13 | $200.26 | |
| 86580 | <1% | 24 | $192.85 | |
| 90651 | <1% | 162 | $136.25 | |
| 90662 | <1% | 13 | $96.00 | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 15 | $93.55 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 17 | $82.00 |
| 81000 | <1% | 34 | $81.33 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 70 | $80.09 |
| 99173 | <1% | 26 | $57.43 | |
| 3077F | <1% | 2,785 | $18.08 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 28 | $6.76 |
| 1160F | 0% | 66 | $0.00 | |
| 1159F | 0% | 43 | $0.00 | |
| 3725F | 0% | 13 | $0.00 | |
| 3016F | 0% | 28 | $0.00 | |
| 3288F | 0% | 13 | $0.00 | |
| A4550 | Surgical trays | 0% | 17 | $0.00 |
| 3080F | 0% | 1,406 | $0.00 | |
| 1170F | 0% | 13 | $0.00 | |
| 3079F | 0% | 1,484 | $0.00 | |
| 3074F | 0% | 615 | $0.00 | |
| 91301 | 0% | 225 | $0.00 | |
| 3075F | 0% | 215 | $0.00 | |
| 2010F | 0% | 65 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| 1111F | 0% | 45 | $0.00 | |
| 1125F | 0% | 40 | $0.00 | |
| 1036F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQASIMYAR, AHMAD (MEDICAL DIRECTOR)